Method Development and Validation for Simultaneous Estimation of Omeprazole and Domperidone by RP-HPLC

 

Govinda Rao Kamala*, Sowjanya Vadrevu, Malipeddi Haripriya

Aditya Pharmacy College, ADB Road, Surampalem, Kakinada, East Godavari District

*Corresponding Author E-mail: govindarao83@gmail.com

 

ABSTRACT:

The developed RP- HPLC method allows rapid and precise determinations of Omeprazole and domperidone, the scope of the present work is to expand and optimization of the chromatographic conditions, to develop RP-HPLC method. A series of mobile phases were tried, among the various mobile phases as methanol and 0.1% ammonium acetate an ideal mobile phase, since it gave a good resolution and peak shapes with perfect optimization. The flow rate was optimized at 1 ml/min. The Linearity and Correlation Coefficient of Omeprazole and Domperidone were found to be 10-50 ug/ml, and 10.10-50.50 ug/ml 0.9996, and 0.998 respectively. The limit of detection for Omeprazole and domperidone was found to be 1.76 and 2.0 and the limit of quantification was found to be 1.87 and 1.48. The method was known to be accurate with the assay method. The % assay was found to be 97 and 98.12. The developed method was showed to a good accuracy and precision. The % RSD is for Omeprazole and Domperidone is 041 and 1.41. The Isocratic elution technique developed for the determination of Omeprazole and domperidone ideally suited for rapid and routine analysis. This method shows that good reproducibility of the results. Furthermore this method was simple, sensitive, and accurate. Degradation studies were done, here the drug stability results were in the range of acceptance criteria 85-115%.

 

KEYWORDS: Omeprazole, Domperidone, Optimization, Method validation, RP-HPLC.

 

 


INTRODUCTION:

Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+ -ATPase in the gastric parietal cell. Domperidone acts as a gastrointestinal emptying (delayed) adjunct and peristaltic stimulant. Several methods have been developed using various chromatographic studies and the scope of the present work is to expand and optimization of the chromatographic conditions, to develop RP-HPLC method. A series of mobile phases were tried, among the various mobile phases as methanol and 0.1% ammonium acetate an ideal mobile phase, since it gave a good resolution and peak shapes with perfect optimization.

 

These drugs are evaluated for linearity, precision, accuracy, LOD, LOQ, Specificity, % Assay, Drug degradation etc

 

High performance liquid chromatography:

High Performance Liquid Chromatography1-5 (HPLC) is the fastest growing analytical technique for the analysis of drugs. Chromatographic separation in HPLC is the result of specific interaction between sample molecules with both the stationary and liquid mobile phases. HPLC has been rapidly developed with the introduction of new pumping methods, more reliable columns and wide range of detectors. HPLC is also being automated which involve automated sampling, separation, detection, recording, calculation and printing of results. HPLC offers a wide choice of chromatographic separation methodologies from normal to reverse phase and whole range of mobile phases using isocratic or gradient elution techniques. Various detectors available for HPLC are electrochemical detectors, refractive index detectors, fluorescence detectors, radiochemical detectors, mass-sensitive detectors and Ultra-violet (UV) detectors6-10. To develop a new HPLC method for any drug, knowledge of its molecular weight, polarity, ionic character, pKa values, wavelength of absorption, purity of compound and the solubility should be known. Method development involves considerable effort and time. The most commonly applied method is reversed phase and reverse coupled with ion-pairing. These two techniques probably account for more than 85% of the applications for a typical pharmaceutical compound. The typical pharmaceutical compounds are considered to be an active pharmaceutical ingredient of molecular weight of less than 1,000 Daltons. Depending on the number of active compounds to be resolved or separated, the more complex is the separation, the more gradient elution will be advantageous over isocratic mode. Optimization11-15 can be started only after reasonable chromatogram has been obtained.

 

Fig:  Schematic Diagram of HPLC Instrument

 

The main objective was to develop a sensitive, simple, rapid, reliable and accurate analytical method for the simultaneous estimation of Omeprazole and Domperidone16 in formulations and validation of developed method by using RP-HPLC technique.

 

MATERIALS AND METHODS:

Instruments:

Shimadzu Separation Module LC-10AT HPLC with UV detector, Waters C18 250×4.6mm. 5µm column, Mettle toledo Electronic balance (sensitivity 0.1mg), Frontline ultra sonicator, Sansel pH meter, Vaccum filter pump (PCI analytics) were used for the measurements.

 

Software used: 

LC Solutions version 1.23

 

Reagents used:

HPLC Grade Methanol was used as the solvent as well as the Mobile phase. It was procured from Rankem, India. Ortho phosphoric acid was purchased from Rankem, India. Pure water for the analysis was prepared by using Millipore Milliq purification system.

 

Chemicals used:

Methanol and ammonium acetate (HPLC Grade).

 

Method development:

Proper selection of HPLC method development depends upon the nature of the sample, its molecular weight and solubility. For successful method development various Chromatographic parameters such as pH, mobile phase, its composition and proportion, detection wavelength and other factors were exhaustively studied.          

 

Selection of Chromatographic method:

Proper selection of method depends up on the nature of the sample, molecular weight, and solubility. The drug selected for the present study was Non polar. Non polar compounds can be separated by either normal phase or reverse phase chromatography Reverse phase chromatography was selected for initial separations from the knowledge of properties of the compounds.

 

Selection of Diluent:

The nature of the drug reveals certain information about the drug such as solubility, pKa. Based on the solubility of the drug, the diluents are selected. The solvent in which the drug has maximum solubility is selected as the diluents. Omeprazole and Domperidone are soluble in Methanol. So methanol is used as Diluent.

 

Selection of detection Wavelength:

Standard solutions of Omeprazole and Domperidone were injected separately as well as in combination into HPLC system then scanned over entire the UV range (190-400nm).The spectra of Omeprazole and Domperidone was recorded for determination of λmax. The λmax Of Omeprazole was detected at 280nm and the λmax of Domperidone was detected at 288nm. Detection was carried out at 280nm.

 

Selection of column:

In reverse phase chromatography non polar stationary phase is used for separation. C8, C18 are the commonly used columns in reverse phase chromatography. Here C18 column of dimensions 250 × 4.6mm and particle size 5μm is used for the separation.

 

Selection of Mobile phase:

A Number of trails were made to find out the mobile phase for eluting the drug. The mobile phase containing Methanol: Ammonium acetate (70:30).

Mode of separation:

Several trails were conducted by changing flow rate, injection volume and other parameters till satisfactory separation were achieved, the resulting chromatograms were recorded and the chromatographic parameters such as column efficiency, theoretical plates were calculated. Finally the condition that gives best result was selected for estimation.

 

Preparation of Standard Stock Solution:

Accurately weigh and transfer 10mg of Omeprazole and 10mg of Domperidone working standard into two separate 10ml clean dry volumetric flasks containing methanol. The solution was sonicated for about 10mins and then made upto volume with methanol.

 

Preparation of sample stock solution:

10 Tablets were taken, powdered and weighed. Average weight was taken. From this amount of powder equivalent to 10mg Omeprazole of and 10mg Domperidone of was taken into 10ml volumetric flask containing mobile phase. The solution was sonicated for 10 mins and made up to volume with mobile phase.

 

Trail and error method:

Six numbers of trials were conducted and the results are Based up on the results the optimized method was determined.

 

Optimized method:

Preparation of Buffers:

Prepared 0.1% Ammonium acetate by dissolving in 1000ml of water.

 

Preparation of Mobile Phase:

Mobile Phase A:

Filtered and degassed Methanol is used as mobile phase-A.

 

Mobile Phase B:

HPLC Grade Ammonium acetate is used as Mobile Phase-B.

 

Optimized method for hplc chromatographic conditions:

Chromatograms are shown in fig.no.1 and 2

Instrument:

HPLC Shimadzu Separation Module LC- 10AT Liquid chromatography.

Column:

Waters C18 Column 250×4.6mm. 5µm

Column Temperature: Ambient

Auto sampler Temperature: Ambient                                                                                                            

Flow rate: 1ml/min

Wave length: 280nm

Run time: 4.8 mins

Injection volume: 20ul/min

Mobile phase: Methanol: 0.1% Ammonium acetate (70:30).

Analytical method validation:

The following parameters were considered for validating the developed method as per ICH guidelines.

 

System suitability parameters:

Mixed working standard solutions were injected and chromatograms were recorded. The system suitability studies were carried out as specified in USP. These parameters include Column efficiency, Resolution, Capacity factor, Theoretical plates and tailing factor. system suitability parameters was shown in table no.1.

 

Acceptance criteria :

The % RSD for the retention times and peak area responses of principal peak from 6 replicate injections of each standard solution should be not more than 2.0%.The number of theoretical plates (N) for the drug peak is not less than 2500.The Tailing factor (T) for the drug peak is not more than 2.0.

 

Linearity:

Preparation of standard stock solution:

Accurately weigh and transfer 50mg of Omeprazole working standard into a 10ml clean dry volumetric flask containing mobile phase and 80mg of Domperidone working standard into a 10ml clean dry volumetric flask containing mobile phase. The solutions were sonicated for about 10mins and then made upto volume with mobile phase.

 

Preparation of Intermediate dilution:

2ml of Omeprazole solution was taken from the prepared standard stock solution in a 10ml volumetric flask and made upto volume with mobile phase. 1.30ml of Domperidone solution was taken from the prepared standard stock solution in a 10ml volumetric flask and made upto volume with mobile phase. based up on this 10, 20, 30, 40, 50µg/ml were prepared and evaluated. Linearity values shown in table -2 and calibration curves are shown in fig no.3 and 4.

 

Acceptance criteria:

 R2value should not be less than 0.98

 

Accuracy:

The closeness of agreement between the true value which is accepted either conventional new value or an accepted reference value and the value found.

 

Preparation of standard stock solution:

Accurately weigh and transfer 50mg of Omeprazole working standard into a 10ml clean dry volumetric flask containing mobile phase and 80mg of Domperidone working standard into a 10ml clean dry volumetric flask containing mobile phase. The solutions were sonicated for about 10mins and then made up to volume with mobile phase. Chromatograms are shown in                 fig no. 5 and 6.

 

Preparation of Intermediate dilution:

2ml of Omeprazole solution was taken from the prepared standard stock solution in a 10ml volumetric flask and made upto volume with mobile phase. 1.30 ml of Domperidone solution was taken from the prepared standard stock solution in a 10ml volumetric flask and made upto volume with mobile phase based up on this 12.5 , 25, 37.5 µg/ml were prepared and evaluated.

 

Acceptance criteria:

The % Recovery for each level should be between 98.0 to 102.0%

 

Precision:

Preparation of standard stock solution:

Accurately weigh and transfer 50mg of Omeprazole working standard into a 10ml clean dry volumetric flask containing mobile phase and 80mg of Domperidone working standard into a 10ml clean dry volumetric flask containing mobile phase. The standard solution was injected for six times and measured the area for all six injections in HPLC. The %RSD for the area of six replicate injections was found to be within the specified limits.

 

Standard Deviation

S.D =

Where, x = Sample,

Xi = Mean value of samples.

N = number of samples.

 

Coefficient of variance / Relative standard deviation:

                Standard Deviation

C.V =                                                          X 100

                           Mean

 

Acceptance criteria:  

The % RSD for the area of six standard injections results should not be more than 2%. Precision values are shown in table no.3.

 

Assay:

Assay of different formulations available in the market was carried by injecting sample corresponding to equivalent weight into HPLC system and percentage purity was found out by following formulae. Recovery studies were carried out. Assay values and observations are shown in table no. 4. Calculate the percentage purity of Omeprazole and Domperidone present in the tablet using the calibration curve.

 

Calculation:

Concentration of tablet = Dilution factor × Sample concentration

 

Robustness:

(a)     Effect of variation of flow rate:

A study was conducted to determine the effect of variation in flow rate by injecting 0.8and 1.2ml/min. Standard solution was prepared and injected into the HPLC system. The retention time values were measured and are given in Table no.5. The chromatograms are shown in Fig.no.7.

 

Acceptance criteria:

Tailing factor and %RSD of Omeprazole and Domperidone standard should not be more than 2.0 for variation in flow rate.

 

(b)     Effect of variation of Mobile phase composition :

A study was conducted to determine the effect of variation in mobilephase composition. Standard solution was prepared and injected into the HPLC system at 45:55 and 55:45. The effect of variation in mobile phase composition was evaluated.

 

Acceptance criteria:

Tailing factor and %RSD of Omeprazole and Domperidone standard should not be more than 2.0 for variation in mobilephase composition.

 

Ruggedness:

Ruggedness is the degree of reproducibility of results obtained by the analysis of the same sample  under  a  variety  of  normal  test  conditions  ie  different  analysts,  laboratories,columns, instruments, reagents, assay temperatures, , different days etc. (ie from laboratory to laboratory, from analyst to analyst.).

 

Acceptance Criteria:

Overall RSD should not be more than 2.0 %

 

Analyst to Analyst variation:

Procedure:

The standard solution is injected for by different analysts and the area for injections in HPLC was measured. The %RSD for the area of replicate injections was found to be within the specified limits. Chromatogramas re shown in fig.no.8.

 

Column to Column variation:

Procedure:

The standard solution is injected for by using different columns and the area for injections in HPLC was measured. The %RSD for the area of replicate injections was found to be within the specified limits.

 

Limit of detection:

This is the lowest concentration in a sample that can be detected, but not necessarily quantitated, under the stated experimental conditions.  The limit of detection is important for impurity tests and the assays of dosages containing low drug levels and placebos. Based on signal to noise. Chromatogramas re shown in fig.no.9 and 10 and limits in table no.6.

 

Limit of quantification:

This  is  the  lowest  concentration  of  analyte  in  a  sample  that  can  be  determined  with acceptable precision and accuracy.  lt is quoted as the concentration yielding a signal-to-noise ratio of  10: 1. Chromatogramas re shown in fig. no. 11 and 12 and limits in table no.7

 

Specificity:

Specificity for an assay ensures that the signal measured comes from the substance of interest,  and  that  there  is  no  interference  from  excipient  and/or  degradation  products and/or impurities. The specificity of the method was demonstrated by establishing a lack of interference from the diluents blank.10µl of the blank solution was injected into the chromatograph. There should not be any interference with the Omeprazole and Domperidone peak. Chromatogramas re shown in fig.no.13.

 

Degradation studies:

Degradation studies involve exposing the sample to a variety of stressed conditions to further evaluate the specificity of degradation products. In this study, the drug substance, drug product, and the combined excipients (or placebos) are each exposed to the stressed conditions. These may include, but are not limited to, heat, light, acidic media, alkaline media, and oxidative environments.

 

RESULTS AND DISCUSSION:

Development of method for the estimation of omeprazole and domperidone:16

Several trails were conducted during the development of a method for the simultaneous estimation of Omeprazole and Domperidone in bulk form. The best peak was shown in below chromatograms. based on these trials an optimized method was developed and the chromatogram was shown below:

 

Table no 1: System suitability parameters of Omeprazole and Domperidone

Parameters

Omeprazole

domperidone

Area

721992

655688

Retention time

3.09

4.51

Theoretical plates

4825

4761

Tailing  factor

1.58

1.46

Resolution

20.25

 


 

Fig.1: Chromatogram for Optimized method

 

 

Fig 2: Chromatogram for system suitability of omeprazole and domperidone

 

Fig no: 3

 

Fig no: 4

 

Accuracy:

Acceptance criteria:

The % Recovery for each level should be 98.0 to 102.

 

Fig no. 5- Chromatogram of 25 µg/ml of Omeprazole

 

Fig no. 5

Fig no. 6 Chromatogram of 25.25 µg/ml of Domperidone

 

 


Precision:

Acceptance criteria: The % RSD for the area of six standard injections results should not be more than 2%.

 

Table No: 3 shows observation on Precision of Omeprazole

Sample Id

Retention Time

Peak Area

1

3

4.51

741818

662999

2

3

4.52

752103

662140

3

3

4.51

721992

655688

4

3

4.52

734772

655923

5

3

4.5

754159

662496

6

3

4.51

743741

651010

Mean

3.00

4.51

741430.83

658376.00

Std. Dev

0.00

0.01

0.01

4899.28

%CV

0.00

0.17

0.17

0.74

 

Robustness:

Acceptance criteria:

Tailing factor and %RSD of Omeprazole and Domperidone standard should not be more than 2.0 for variation in flow rate. A study was conducted to determine the effect of variation in mobile phase composition. Standard solution was prepared and injected into the HPLC system at 45:55 and 55:45. The effect of variation in mobile phase composition was evaluated. The retention time values were measured.

 

Table No.4: Assay of two drug formuations

Formulation

Labeled claim (mg)

% of  Assay

FYNAL-OZ (Dr. REDDY’S LABORATORIES LTD)

OMEPRAZOLE-250

97

 

DOMPERIDONE-500

98.12

 

Table No: 5 Robustness of Domperidone

Proposed variations

Asymmetry factor

Acceptance Criteria

Variation in Flow Rate

0.9ml

1.44

 

In between 0.5  and 2.0

1.1ml

1.48

Variation in mobile phase composition

65:35

1.33

75:25

1.59

 


 

Fig no.7: Chromatogram of Mobile phase composition variation 75:25

 

Ruggedness: Acceptance Criteria:  Overall RSD should not be more than 2.0

 

Fig 8: Chromatogram of Analyst variation

 

Fig no.9and10: Chromatogram of LOD_1 of Omeprazole and Domperidone

 

 


Limit of Detection:

This is the lowest concentration in a sample that can be detected, but not necessarily quantitated, under the stated experimental conditions. The limit of detectioisimportant for impurity tests and the assays of dosages containing low drug levels and placebos.

 

Table No.6:  LOD  limits Based on signal to noise ratio

Approach

LOD

Visual Inspection

Minimum level detectable

Signal-to- Noise Ratio

 3:1

SD of response (σ) and slope (S)

{3.3×σ}/s

 

Limit of Quantification:

This is the lowest concentration of analyte in a sample that can be determined with acceptable precision and accuracy. lt is quoted as the concentration yielding a signal-to-noise ratio of 10: 1 .

 

Table No.7:  LOQ limits Based on signal to noise ratio

Approach

LOQ

Visual Inspection

Minimum level quantifiable

Signal-to- Noise Ratio

 10:1

SD of response (σ) and slope (S)

{10.0×σ}/s

 

Fig no.11: Chromatogram of LOQ of Omeprazole.

 

Fig no. 12: Chromatogram of LOQ of Domperidone

 

Specificity:

There should not be any interference with the Omeprazole and Domperidone peak.

 

Omeprazole and domperidone sample:

 

Fig NO.13: Chromatogram of omeprazole and domperidone sample:

 

Table No.8: Results of all the parameters and acceptance criteria

S.NO

PARAMETER

ACCEPTANCE CRITERIA

RESULTS OBTAINED

1

System Suitability

Theoretical Plates-NLT2000

OME-4720.50

DOM- 5526.83

2

Assay

%RSD of OME NMT2%

%RSD of DOM NMT2%

OME- 0.66

DOM – 0.74

3

Method Precision

%RSD of OME NMT2%

%RSD of DOM NMT2%

OME- -1.10

DOM- 1.01

4

Limit of Detection

%RSD of OME NMT2%

%RSD of DOM NMT2%

OME-1.76

DOM- 2.0

5

Limit of Quantification

%RSD of OME NMT2%

%RSD of DOM NMT2%

OME-1.87

DOM- 1.48

6

Linearity

Correlation coefficient NLT 0.996

OME-0.999.7

DOM- 0.998

7

Accuracy

Percentage Recovery

98-102%

OME-97

DOM- 98.6

 

 


Degradation studies:

Degradation studies involve exposing the sample to a variety of stressed conditions to further evaluate the specificity of degradation products. In this study, the drug substance, drug product, and the combined excipients (or placebos) are each exposed to the stressed conditions. These may include, but are not limited to, heat, light, acidic media, alkaline media, and oxidative environments. No specific degradation was seen.

 

CONCLUSION:

The RP-HPLC method for analysis of Omeprazole and domperidone was found to be accurate and precise. The proposed method was validated according to ICH guidelines and correlating the obtained values with the standard values, satisfactory results were obtained. Since this Project can be useful for further research of Omeprazole and domperidone.

 

REFERENCES:

1.        Skoog, D.A., Holler, F.J. and Nieman, T.A.; Principles of Instrumental Analysis, 5th edition. Thomson Books Cole, 2004, P-724.

2.        David CL, Michael Webb. Pharmaceutical Analysis. London: Black well publishing; 1994. p. 2-4.

3.        Beckett AH, Stenlake JB. Practical Pharmaceutical. Vol. 2. New Delhi: CBS Publisher and Distributors; 1986. p. 13-17.

4.        International Conference on Harmonization, “Guidance for Industry: Q2B Validation of Analytical Procedures: Methodology,” 1996 (10).

5.        Bhuvnesh et al; (2014). Development and validation of RP-HPLC method for the simultaneous estimation of omeprazole and domperidone from different capsules. The Pharma research. 10 (2), 34-45.

6.        Anita S. Kulkarni et al; (2012). Method development and validation for the simultaneous determination of omeprazole and domperidone in solid dosage form by RP-HPLC. Int J Pharm. 4 (5), 975-1491.

7.        Srinavasa Rao. et al;  (2014). 5. Development and validation of a reversed-phase hplc method for simultaneous determination of domperidone in tablet dosage form. World Journal of Pharmacy and Pharmaceutical Sciences. 3 (11), 1136-45.

8.        Sudhakar, et al. (2014). Development and validation of uv spectrophotometric method for the estimation of omeprazole in bulk and pharmaceutical formulation. Int J Pharm .4 (1), 247-251.

9.        Aruna K Vanka. et al;  (2013). Development and validation of RP - HPLC method for simultaneous estimation of famotidine and domperidone in pharmaceutical dosage form. Int J Pharm. 5 (1), 223-227.

10.     Dudhe P. B. et al; (2014). 6. Development and Validation of analytical methods for Simultaneous Estimation of Domperidone and Esomeprazole Magnesium in Bulk and in Pharmaceutical Formulations using UV-visible Spectroscopy.  Int J Pharm. 6 (5), 1501-08.

11.     M. Varalakshmi,  J. Vijaya Ratna , K. Krishna Chaitanya ,D. Samson Israel. RP-HPLC method development and validation of domperidone maleate.

12.     Kalakonda Sri Nataraj , Mohammad Badrud Duza , Kalyani Pragallapati , Dussa Kiran    Kumar Development and validation of RP-HPLC method for the estimation of omeprazole in bulk and capsule dosage forms

13.     Bhuvnesh Kumar Singh, Anuj Mittal, Anuj Agrawal, Neelanchal Trivedi, Sachin kumar, Keshari Kishore Jha development and validation of rp-hplc method for the simultaneous estimation of omeprazole and domperidone from different capsules

14.     D. Priya et al; (2012) RP-HPLC Method Development and Validation of the estimation of Cinitapride ans Omeprazole in solid Dosage form. International Journal of Pharmacy and Pharmaceutical sciences.

15.     Gandhi et al; (2009) High-performance thin-layer chromatographic determination of rabeprazole sodium and domperidone in combined dosage form.

16.     R.A Tamboli, V.C. Chauhan, M.M. Pathan, S.K. Tirgar, D.A. Shah, R.R. Parmar Development And Validation of RP-HPLC Method For Simultaneous Estimation Of Ilaprazole and Domperidone In Pharmaceutical Dosage Form.

 

 

Received on 03.12.2015          Accepted on 25.12.2015        

© Asian Pharma Press All Right Reserved

Asian J. Pharm. Ana. 5(4): October- December, 2015; Page 195-205

DOI: 10.5958/2231-5675.2015.00031.9